INHIBRX BIOSCIENCES, INC. — Balance Sheet Charts
8 snapshots of history · ending 2025-12-31 · SEC EDGAR
Source:10-K · 10-Q
Assets vs Liabilities
Cash Position Breakdown
Debt Structure
Working Capital Components
Capital Structure (LT Debt / Cash / Equity)
Total Assets↓-19.0% -$34M
$146M
Current Assets↓-17.2% -$28M
$133M
Cash & Equivalents↓-18.6% -$28M
$124M
Net PPE↓-39.8% -$2M
$4M
Total Liabilities↑+193.5% +$91M
$138M
Current Liabilities↓-17.0% -$7M
$34M
Account Payables↓-35.7% -$3M
$6M
Long-Term Debt
$101M
Stockholders Equity↓-94.0% -$126M
$8M
Retained Earnings↓-132.0% -$140M
$-246M
Operating Lease ROU Asset↓-24.6% -$2M
$6M
Operating Lease Liability↓-19.8% -$2M
$6M
Gross PP&E↓-1.6% -$239K
$15M
Accumulated Depreciation↑+25.1% +$2M
$11M